PPR-006 - The vulnerable populations’ inclusiveness in pharmaceutical care (VIP-Care) Project: Validating a battery of tests and assessing pharmacists’ attitudes in community setting

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: PPR-006
• By: HAJJ, Aline (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Lebanon)
• Co-author(s): Dr Aline Hajj (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 2 Faculté de Pharmacie, Université Laval, Québec, Canada / 3 Oncology Division, CHU de Québec Université Laval Research Center, Québec, Canada)
  Dr Hala Sacre (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon)
  Dr Jihan Safwan (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 4School of Pharmacy, Lebanese International University, Beirut, Lebanon)
  Dr Soukaina Basma (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 5Faculty of Pharmacy, Lebanese University, Hadat, Lebanon)
  Dr Chadia Haddad (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 66 Research Department, Psychiatric Hospital of the Cross, Jal El Dib, Lebanon / 7Faculty of Public Health, Lebanese University, Fanar, Lebanon)
  Dr Zeinab Abbas (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 4School of Pharmacy, Lebanese International University, Beirut, Lebanon)
  Dr Nisreen Mourad (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 4School of Pharmacy, Lebanese International University, Beirut, Lebanon)
  Dr Samar Younes (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 4School of Pharmacy, Lebanese International University, Beirut, Lebanon)
  Dr Carla Bou Selwan (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon)
  Dr Rony Zeenny (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 8Pharmacy department, American University of Beirut Medical Center, Beirut, Lebanon)
  Dr Marwan Akel (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon)
  Prof Pascale Salameh (1 Institut National de Santé Publique, d’Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon / 5Faculty of Pharmacy, Lebanese University, Hadat, Lebanon / 9Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Beirut, Lebanon, Beirut, Lebanon / 10Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus)
  
• Abstract:

  Introduction: Inclusiveness in healthcare is a multifaceted theoretical concept encompassing inclusivity, diversity, and equity. Inclusiveness can be affected by healthcare professionals’ ethical attitudes and moral behaviours, emotional intelligence, and well-being. This project aimed to validate a battery of tests and a composite scale to..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login